Oxford American Handbook of Oncology

Description

• Evidence-based guidance on clinical decision making, treatment options, and therapeutic regimens
• Algorithms, practice guidelines, highlight tables, and landmark references
• Covers cancer biology, genetics, prevention and screening, and complications and supportive care

The Oxford American Handbook of Oncology is the essential reference for medical students, residents, and clinical oncologists seeking a current, portable resource on the delivery of sophisticated cancer care. Chapters focus on the immediate information needs in clinical decision making including treatment choices. Algorithms, best practice guidelines, highlighted tables, and targeted lists of landmark references enhance the concise text. For the second edition biologic therapies and therapeutic regimens and options and clinical trial information have been rigorously updated throughout.

Readership: Medical students, residents, and clinical oncologists.

Table of Contents

Part 1 Background
1 Molecular cancer biology
2 Etiology and epidemiology
Part 2 Cancer prevention and screening
3 Cancer prevention
4 Cancer screening
5 Genetic screening
Part 3 Principles of management
6 Principles of cancer treatment
7 Surgical oncology
8 Principles of radiation oncology
9 Principles of chemotherapy
10 Hematopoietic stem cell transplantation
11 Hormone therapy
12 Targeted therapies
13 Gene therapy and immunotherapy for cancer
14 Complementary and alternative medicine
15 Clinical trials
Part 4 Complications and supportive care
16 Anemia and fatigue
17 Febrile neutropenia
18 Pain management
19 Venous thromboembolism
20 Metabolic emergencies
21 Paraneoplastic syndromes
22 Superior vena cava syndrome and raised intracranial pressure
23 Spinal cord compression
24 Other obstructive complications
25 Late effects of cancer treatment
26 End-of-life care
Part 5 Specific cancers
27 Thoracic cancers
28 Breast cancer
29 Gastrointestinal cancer I: esophagus, stomach, small intestine, carcinoid
30 Gastrointestinal cancer II: pancreas, biliary tract, hepatocellular
31 Gastrointestinal cancer III: colorectal, anus
32 Endocrine cancers
33 Genitourinary cancer I: renal, bladder, ureter, penile carcinomas
34 Genitourinary cancer II: prostate cancer
35 Genitourinary cancer III: testicular cancer
36 Gynecological cancer
37 Tumors of the central nervous system
38 Head and neck cancers
39 Cutaneous malignancies
40 Soft tissue and bone sarcomas
41 Acute leukemia
42 Chronic leukemias and myelodysplastic syndromes
43 Multiple myeloma
44 Malignant lymphoma
45 Cancer of unknown primary (CUP)
Appendix

Authors

Edited by Gary H. Lyman, Professor of Medicine and Director of Health Services and Outcomes Research, Division of Medical Oncology, Duke University Medical Center, Duke Comprehensive Cancer Center

Gary H Lyman: Co-Director, Hutchinson Institute for Cancer Outcomes Research; Affiliate Professor, University of Washington Schools of Public Health and Pharmacy, Seattle, WA